https://novapharmanews.com/eu/news/myasthenia-gravis-clinical-trial-pipeline-expands-25-companies-delveinsight 2026-06-05T10:49:48.305Z NovaPharmaNews en 2026-06-05T03:14:34.382Z Myasthenia Gravis Clinical Trial Pipeline Expands as 25+ Companies Race to Redefine Myasthenia Gravis Treatment Landscape | DelveInsight — regulatory updates myasthenia gravis https://novapharmanews.com/uploads/articles/myasthenia-gravis-clinical-trial-pipeline-expands-25-companies-delveinsight.webp Myasthenia Gravis Clinical Trial Pipeline Expands as 25+ Companies Race to Redefine Myasthenia Gravis Treatment Landscape | DelveInsight — regulatory updates https://novapharmanews.com/eu/news/mfn-drug-pricing-reshapes-international-life-sciences-licensing-deals 2026-06-05T11:07:32.750Z NovaPharmaNews en 2026-06-05T03:09:13.231Z MFN Drug Pricing Reshapes International Life Sciences Licensing Deals https://novapharmanews.com/uploads/articles/mfn-drug-pricing-reshapes-international-life-sciences-licensing-deals.webp MFN Drug Pricing Reshapes International Life Sciences Licensing Deals https://novapharmanews.com/eu/news/india-oman-cepa-fast-tracks-drug-approvals-cuts-export-barriers 2026-06-05T12:04:31.685Z NovaPharmaNews en 2026-06-05T02:54:41.963Z India-Oman CEPA Fast-Tracks Drug Approvals, Cuts Export Barriers for Pharma https://novapharmanews.com/uploads/articles/india-oman-cepa-fast-tracks-drug-approvals-cuts-export-barriers.webp India-Oman CEPA Fast-Tracks Drug Approvals, Cuts Export Barriers for Pharma https://novapharmanews.com/us/news/fda-approves-companion-diagnostic-inavolisib-hr-her2-pik3ca-mutated-breast-cancer 2026-06-05T05:05:15.934Z NovaPharmaNews en 2026-06-05T02:32:18.666Z FDA Approves Companion Diagnostic for Inavolisib in HR+/HER2–, PIK3CA-Mutated Breast Cancer inavolisib, palbociclib, fulvestrant, FoundationOne CDx, FoundationOne Liquid CDx, oncology, breast cancer, HR+/HER2–, PIK3CA-mutated breast cancer, endocrine-resistant, PIK3CA-mutated, HR-positive, HER2-negative, advanced breast cancer https://novapharmanews.com/uploads/articles/fda-approves-companion-diagnostic-inavolisib-hr-her2-pik3ca-mutated-breast-cancer.webp FDA Approves Companion Diagnostic for Inavolisib in HR+/HER2–, PIK3CA-Mutated Breast Cancer https://novapharmanews.com/us/news/peptide-reclassification-rfk-jr-fda-announcement-pharmacist-take 2026-06-05T06:55:25.105Z NovaPharmaNews en 2026-06-05T01:39:48.737Z The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means — drug approvals https://novapharmanews.com/uploads/articles/peptide-reclassification-rfk-jr-fda-announcement-pharmacist-take.webp The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means — drug approvals https://novapharmanews.com/apac/news/vietnam-india-middle-power-diplomacy-pharma-market-analysis 2026-06-05T10:53:29.596Z NovaPharmaNews en 2026-06-05T00:37:08.409Z Vietnam and India Reshape Middle Power Diplomacy: Market Analysis for Pharma https://novapharmanews.com/uploads/articles/vietnam-india-middle-power-diplomacy-pharma-market-analysis.webp Vietnam and India Reshape Middle Power Diplomacy: Market Analysis for Pharma https://novapharmanews.com/us/news/scientists-uncover-new-hiding-spot-hiv-bone-marrow 2026-06-05T10:53:10.947Z NovaPharmaNews en 2026-06-05T00:23:35.461Z Scientists uncover a new hiding spot for HIV in bone marrow: Implications for cure research HIV https://novapharmanews.com/uploads/articles/scientists-uncover-new-hiding-spot-hiv-bone-marrow.webp Scientists uncover a new hiding spot for HIV in bone marrow: Implications for cure research https://novapharmanews.com/us/news/trump-administration-strips-job-protections-nih-officials-pharma-impact 2026-06-05T12:54:28.365Z NovaPharmaNews en 2026-06-04T07:08:57.385Z Trump Administration Strips Job Protections of Top NIH Officials: What Pharma Teams Must Know https://novapharmanews.com/uploads/articles/trump-administration-strips-job-protections-nih-officials-pharma-impact.webp Trump Administration Strips Job Protections of Top NIH Officials: What Pharma Teams Must Know https://novapharmanews.com/apac/news/nmpa-drug-approvals-2025-record-first-global-approvals 2026-06-05T09:15:55.623Z NovaPharmaNews en 2026-06-04T03:21:58.215Z NMPA Drug Approvals Surge in 2025: Record 61 First Global Approvals Signal Accelerated Market Access https://novapharmanews.com/uploads/articles/nmpa-drug-approvals-2025-record-first-global-approvals.webp NMPA Drug Approvals Surge in 2025: Record 61 First Global Approvals Signal Accelerated Market Access https://novapharmanews.com/eu/news/ema-ama-african-regulators-ebola-clinical-trials-2026 2026-06-04T14:58:54.181Z NovaPharmaNews en 2026-06-04T03:00:14.543Z EMA, AMA and African Regulators Unite to Accelerate Ebola Clinical Trials Ebola https://novapharmanews.com/uploads/articles/ema-ama-african-regulators-ebola-clinical-trials-2026.webp EMA, AMA and African Regulators Unite to Accelerate Ebola Clinical Trials https://novapharmanews.com/us/news/pharma-in-focus-regulatory-updates 2026-06-05T05:44:45.013Z NovaPharmaNews en 2026-06-04T02:48:21.704Z Pharma in Focus: Regulatory Updates You Need to Know https://novapharmanews.com/uploads/articles/pharma-in-focus-regulatory-updates.webp Pharma in Focus: Regulatory Updates You Need to Know https://novapharmanews.com/apac/news/smarter-medical-devices-ecosystem-india-regulatory-updates 2026-06-05T09:16:05.316Z NovaPharmaNews en 2026-06-04T02:48:21.704Z Building a Smarter Medical Devices Ecosystem in India: Regulatory Updates healthcare technologies, medical devices https://novapharmanews.com/uploads/articles/smarter-medical-devices-ecosystem-india-regulatory-updates.webp Building a Smarter Medical Devices Ecosystem in India: Regulatory Updates https://novapharmanews.com/eu/news/eu-commission-advances-critical-medicines-act 2026-06-04T12:38:13.357Z NovaPharmaNews en 2026-06-04T02:48:21.704Z EU Commission Advances Critical Medicines Act: Market Implications https://novapharmanews.com/uploads/articles/eu-commission-advances-critical-medicines-act.webp EU Commission Advances Critical Medicines Act: Market Implications https://novapharmanews.com/eu/news/chmp-negative-stance-acadia-rett-syndrome-drug 2026-06-05T08:49:38.997Z NovaPharmaNews en 2026-06-04T02:48:21.704Z CHMP Negative Opinion on Acadia's Rett Syndrome Drug: Implications for Investors and Pharma Teams Rett syndrome https://novapharmanews.com/uploads/articles/chmp-negative-stance-acadia-rett-syndrome-drug.webp CHMP Negative Opinion on Acadia's Rett Syndrome Drug: Implications for Investors and Pharma Teams https://novapharmanews.com/us/news/astrazeneca-daiichi-drug-approval-breast-cancer 2026-06-05T09:58:32.595Z NovaPharmaNews en 2026-06-04T02:48:21.704Z AstraZeneca and Daiichi's Datroway (Dato-DXd) Approved for Triple-Negative Breast Cancer: Implications for Pharma breast cancer, triple-negative breast cancer https://novapharmanews.com/uploads/articles/astrazeneca-daiichi-drug-approval-breast-cancer.webp AstraZeneca and Daiichi's Datroway (Dato-DXd) Approved for Triple-Negative Breast Cancer: Implications for Pharma https://novapharmanews.com/eu/news/owkin-astrazeneca-ai-collaboration-drug-research 2026-06-05T13:41:21.124Z NovaPharmaNews en 2026-06-04T02:48:21.704Z Owkin and AstraZeneca Enhance AI Collaboration for Drug Research https://novapharmanews.com/uploads/articles/owkin-astrazeneca-ai-collaboration-drug-research.webp Owkin and AstraZeneca Enhance AI Collaboration for Drug Research https://novapharmanews.com/us/news/fierce-biotech-week-2026-recap 2026-06-05T13:48:40.894Z NovaPharmaNews en 2026-06-04T02:48:21.704Z Fierce Biotech Week 2026: Key Insights and Highlights https://novapharmanews.com/uploads/articles/fierce-biotech-week-2026-recap.webp Fierce Biotech Week 2026: Key Insights and Highlights https://novapharmanews.com/apac/news/cell-gene-therapy-approvals-china-regulatory-updates 2026-06-05T14:05:57.198Z NovaPharmaNews en 2026-06-04T02:48:21.704Z Cell and Gene Therapy Approvals in China: Latest Regulatory Updates gene therapy https://novapharmanews.com/uploads/articles/cell-gene-therapy-approvals-china-regulatory-updates.webp Cell and Gene Therapy Approvals in China: Latest Regulatory Updates https://novapharmanews.com/eu/news/cancer-therapy-ost-her2-2026-ema-call 2026-06-05T14:26:21.826Z NovaPharmaNews en 2026-06-04T02:48:21.704Z Cancer Therapy OST-HER2 Faces 2026 EMA Call After Survival Data OST-HER2, cancer https://novapharmanews.com/uploads/articles/cancer-therapy-ost-her2-2026-ema-call.webp Cancer Therapy OST-HER2 Faces 2026 EMA Call After Survival Data https://novapharmanews.com/eu/news/hayes-esmo-breast-cancer-award-2026 2026-06-05T08:25:38.864Z NovaPharmaNews en 2026-06-04T02:48:21.704Z Hayes Receives 2026 ESMO Breast Cancer Award: Key Insights breast cancer https://novapharmanews.com/uploads/articles/hayes-esmo-breast-cancer-award-2026.webp Hayes Receives 2026 ESMO Breast Cancer Award: Key Insights https://novapharmanews.com/apac/news/decade-ai-medical-device-regulation-2015-2025 2026-06-05T09:14:40.485Z NovaPharmaNews en 2026-06-04T02:48:21.704Z A Decade of AI Medical Device Regulation: Key Updates for Pharma https://novapharmanews.com/uploads/articles/decade-ai-medical-device-regulation-2015-2025.webp A Decade of AI Medical Device Regulation: Key Updates for Pharma https://novapharmanews.com/eu/news/chmp-may-2026-output-shift-european-drug-development 2026-06-05T13:33:56.946Z NovaPharmaNews en 2026-06-04T02:48:21.704Z CHMP May 2026 Output: A New Era in Drug Approvals https://novapharmanews.com/uploads/articles/chmp-may-2026-output-shift-european-drug-development.webp CHMP May 2026 Output: A New Era in Drug Approvals https://novapharmanews.com/eu/news/who-europe-access-novel-medicines 2026-06-05T12:31:41.515Z NovaPharmaNews en 2026-06-04T02:48:21.704Z WHO/Europe Initiative on Access to Novel Medicines: Market Implications for Pharma https://novapharmanews.com/uploads/articles/who-europe-access-novel-medicines.webp WHO/Europe Initiative on Access to Novel Medicines: Market Implications for Pharma https://novapharmanews.com/us/news/fda-flashback-breast-cancer-april-2026 2026-06-05T13:49:51.283Z NovaPharmaNews en 2026-06-04T02:48:21.704Z FDA Flashback: Key Breast Cancer Decisions from April 2026 breast cancer https://novapharmanews.com/uploads/articles/fda-flashback-breast-cancer-april-2026.webp FDA Flashback: Key Breast Cancer Decisions from April 2026 https://novapharmanews.com/eu/news/esmo-asia-nadia-harbeck-oncology-advances 2026-06-05T09:29:11.867Z NovaPharmaNews en 2026-06-04T02:48:21.704Z Insights from ESMO Asia: Nadia Harbeck on Oncology Advances oncology https://novapharmanews.com/uploads/articles/esmo-asia-nadia-harbeck-oncology-advances.webp Insights from ESMO Asia: Nadia Harbeck on Oncology Advances https://novapharmanews.com/us/news/fda-approves-first-oral-covid-19-pep-drug-xocova 2026-06-05T10:56:22.301Z NovaPharmaNews en 2026-06-04T01:54:35.580Z FDA Approves First Oral COVID-19 PEP Drug, Xocova XOCOVA, ensitrelvir, Veklury, remdesivir, COVID-19 https://novapharmanews.com/uploads/articles/fda-approves-first-oral-covid-19-pep-drug-xocova.webp FDA Approves First Oral COVID-19 PEP Drug, Xocova https://novapharmanews.com/us/news/legend-biotech-in-vivo-car-t-lymphoma-data-surge 2026-06-04T18:10:53.737Z NovaPharmaNews en 2026-06-04T01:03:07.735Z Legend Biotech surges on early in vivo CAR-T data for lymphoma Kymriah, in vivo CAR-T, cell therapy, lymphoma, blood cancer https://novapharmanews.com/uploads/articles/legend-biotech-in-vivo-car-t-lymphoma-data-surge.webp Legend Biotech surges on early in vivo CAR-T data for lymphoma https://novapharmanews.com/us/news/halomd-lawsuit-update-highmark-health-no-surprises-act 2026-06-05T13:24:28.270Z NovaPharmaNews en 2026-06-03T23:40:28.314Z HaloMD Lawsuit Update: Highmark Health Alleges 'Sham Letter' and Misleading Data in No Surprises Act Dispute https://novapharmanews.com/uploads/articles/halomd-lawsuit-update-highmark-health-no-surprises-act.webp HaloMD Lawsuit Update: Highmark Health Alleges 'Sham Letter' and Misleading Data in No Surprises Act Dispute https://novapharmanews.com/apac/news/regulatory-round-up-drug-approvals-18-may-2026 2026-06-04T02:55:42.914Z NovaPharmaNews en 2026-06-03T19:23:49.735Z Regulatory Round-Up: Key Drug Approvals on May 18, 2026 https://novapharmanews.com/uploads/articles/regulatory-round-up-drug-approvals-18-may-2026.webp Regulatory Round-Up: Key Drug Approvals on May 18, 2026 https://novapharmanews.com/eu/news/us-europe-biosimilar-approvals-2026 2026-06-05T11:26:03.507Z NovaPharmaNews en 2026-06-03T19:10:52.379Z Biosimilar Approvals: U.S. vs. Europe Insights for Pharma BD https://novapharmanews.com/uploads/articles/us-europe-biosimilar-approvals-2026.webp Biosimilar Approvals: U.S. vs. Europe Insights for Pharma BD https://novapharmanews.com/eu/news/key-cancer-drugs-esmo-2025 2026-06-05T04:41:26.296Z NovaPharmaNews en 2026-06-03T19:05:29.875Z Key Cancer Drugs to Watch at ESMO 2025: Investor and BD Insights cancer https://novapharmanews.com/uploads/articles/key-cancer-drugs-esmo-2025.webp Key Cancer Drugs to Watch at ESMO 2025: Investor and BD Insights https://novapharmanews.com/us/news/stat-trump-s-medicaid-work-requirements-have-an-unwelcome-surprise-for-some-states-and-patients 2026-06-05T14:32:05.191Z NovaPharmaNews en 2026-06-03T18:49:07.382Z STAT+: Trump’s Medicaid work requirements have an unwelcome surprise for some states and patients https://novapharmanews.com/uploads/articles/stat-trump-s-medicaid-work-requirements-have-an-unwelcome-surprise-for-some-states-and-patients.webp STAT+: Trump’s Medicaid work requirements have an unwelcome surprise for some states and patients https://novapharmanews.com/us/news/military-eating-disorders-prevalence-impact 2026-06-04T21:39:32.549Z NovaPharmaNews en 2026-06-03T18:49:06.601Z The Military's Role in the Rising Tide of Eating Disorders eating disorders https://novapharmanews.com/uploads/articles/military-eating-disorders-prevalence-impact.webp The Military's Role in the Rising Tide of Eating Disorders https://novapharmanews.com/eu/news/european-navenibart-deal-biocryst-analysis 2026-06-04T04:14:53.936Z NovaPharmaNews en 2026-06-03T18:10:13.708Z European Navenibart Deal: A Strategic Win for BioCryst's Rare Disease Portfolio Navenibart, rare disease https://novapharmanews.com/uploads/articles/european-navenibart-deal-biocryst-analysis.webp European Navenibart Deal: A Strategic Win for BioCryst's Rare Disease Portfolio https://novapharmanews.com/apac/news/risen-pharma-phase-2-trial-rp902-alzheimers 2026-06-04T04:14:57.938Z NovaPharmaNews en 2026-06-03T18:00:50.146Z Risen Pharma Initiates Phase 2 Trial for RP902 in Alzheimer's RP902, Alzheimer's disease, Mild Cognitive Impairment https://novapharmanews.com/uploads/articles/risen-pharma-initiates-phase-2-trial-for-rp902-in-alzheimer-s.webp Risen Pharma Initiates Phase 2 Trial for RP902 in Alzheimer's https://novapharmanews.com/us/news/fda-blueprint-regulatory-risk-animal-testing-alternatives 2026-06-05T09:24:05.577Z NovaPharmaNews en 2026-06-03T17:42:14.685Z FDA Blueprint Aims to Reduce Regulatory Risks for Animal Testing Alternatives https://novapharmanews.com/uploads/articles/fda-blueprint-regulatory-risk-animal-testing-alternatives.webp FDA Blueprint Aims to Reduce Regulatory Risks for Animal Testing Alternatives https://novapharmanews.com/apac/news/regulatory-updates-optical-coherence-tomography-pharma 2026-06-05T14:03:00.209Z NovaPharmaNews en 2026-06-03T17:18:44.483Z Optical Coherence Tomography Gains Regulatory Traction in Pharma Filings https://novapharmanews.com/uploads/articles/regulatory-updates-optical-coherence-tomography-pharma.webp Optical Coherence Tomography Gains Regulatory Traction in Pharma Filings https://novapharmanews.com/us/news/china-drug-development-oncology-us 2026-06-05T09:33:30.402Z NovaPharmaNews en 2026-06-03T17:07:37.783Z China’s Rise in Drug Development Looms Over U.S. Oncology Market oncology, lung cancer https://novapharmanews.com/uploads/articles/china-s-rise-in-drug-development-looms-over-u-s-oncology-market.webp China’s Rise in Drug Development Looms Over U.S. Oncology Market https://novapharmanews.com/eu/news/horizon-scanning-ema-regulatory-updates 2026-06-05T13:53:16.940Z NovaPharmaNews en 2026-06-03T16:59:25.064Z EMA Horizon Scanning: Navigating Regulatory Updates for Future Medicines https://novapharmanews.com/uploads/articles/horizon-scanning-ema-regulatory-updates.webp EMA Horizon Scanning: Navigating Regulatory Updates for Future Medicines https://novapharmanews.com/apac/news/datroway-approved-metastatic-tnbc 2026-06-04T10:22:15.001Z NovaPharmaNews en 2026-06-03T16:51:22.911Z Datroway Approved: A New Hope for Metastatic TNBC Patients Datroway, metastatic TNBC, metastatic triple-negative breast cancer https://novapharmanews.com/uploads/articles/datroway-approved-metastatic-tnbc.webp Datroway Approved: A New Hope for Metastatic TNBC Patients https://novapharmanews.com/eu/news/x4-pharmaceuticals-ema-chmp-positive-opinion-mavorixafor 2026-06-05T00:39:27.870Z NovaPharmaNews en 2026-06-03T16:43:07.991Z X4 Pharmaceuticals Secures Positive EMA CHMP Opinion for Mavorixafor in WHIM Syndrome Mavorixafor, WHIM Syndrome https://novapharmanews.com/uploads/articles/x4-pharmaceuticals-ema-chmp-positive-opinion-mavorixafor.webp X4 Pharmaceuticals Secures Positive EMA CHMP Opinion for Mavorixafor in WHIM Syndrome https://novapharmanews.com/us/news/fda-declines-guidance-foreign-drug-imports 2026-06-05T03:53:51.734Z NovaPharmaNews en 2026-06-03T16:07:48.130Z FDA Declines Guidance on Foreign Drug Imports: Impact on Pharma BD and Investors https://novapharmanews.com/uploads/articles/fda-declines-guidance-foreign-drug-imports.webp FDA Declines Guidance on Foreign Drug Imports: Impact on Pharma BD and Investors https://novapharmanews.com/eu/news/privosegtor-ema-prime-optic-neuritis 2026-06-05T10:29:52.190Z NovaPharmaNews en 2026-06-03T16:04:42.681Z Privosegtor Secures EMA PRIME Designation for Optic Neuritis Treatment optic neuritis https://novapharmanews.com/uploads/articles/privosegtor-ema-prime-optic-neuritis.webp Privosegtor Secures EMA PRIME Designation for Optic Neuritis Treatment https://novapharmanews.com/eu/news/arrowhead-pharmaceuticals-positive-cardiometabolic-data-european-a 2026-06-05T10:50:53.257Z NovaPharmaNews en 2026-06-03T15:44:55.661Z Arrowhead Pharmaceuticals Presents Positive Cardiometabolic Data at European A Meeting Cardiometabolic disorders https://novapharmanews.com/uploads/articles/arrowhead-pharmaceuticals-positive-cardiometabolic-data-european-a.webp Arrowhead Pharmaceuticals Presents Positive Cardiometabolic Data at European A Meeting https://novapharmanews.com/eu/news/teva-olan-ema-acceptance 2026-06-04T04:14:41.416Z NovaPharmaNews en 2026-06-03T15:33:17.329Z Teva's Olan EMA Application Acceptance: Strategic Implications for Pharma Olan https://novapharmanews.com/uploads/articles/teva-olan-ema-acceptance.webp Teva's Olan EMA Application Acceptance: Strategic Implications for Pharma https://novapharmanews.com/eu/news/florian-lordick-esmo-president-2026-elections-open 2026-06-04T21:33:38.387Z NovaPharmaNews en 2026-06-03T15:30:06.756Z Florian Lordick Elected 2026 ESMO President: Implications for Global Oncology oncology https://novapharmanews.com/uploads/articles/florian-lordick-elected-2026-esmo-president-implications-for-global-oncology.webp Florian Lordick Elected 2026 ESMO President: Implications for Global Oncology